Showing results (1361-1370 of 1,597) with videos related to
Sort By:
Pageof 160
Journal of the American Heart Association|May 31, 2017
Role of B-Type Natriuretic Peptide and N-Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes MellitusEmil Wolsk, Brian Claggett, Marc A Pfeffer, et al.Diabetes Care|April 23, 2013
Genetic information and the prediction of incident type 2 diabetes in a high-risk multiethnic population: the EpiDREAM genetic studySonia S Anand, David Meyre, Guillaume Pare, et al.Diabetologia|June 6, 2022
Obesity in late adolescence and incident type 1 diabetes in young adulthoodInbar Zucker, Yair Zloof, Aya Bardugo, et al.Science (New York, N.Y.)|March 20, 2010
Variation in transcription factor binding among humansMaya Kasowski, Fabian Grubert, Christopher Heffelfinger, et al.European Heart Journal|October 10, 2024
Great debate: pre-diabetes is not an evidence-based treatment target for cardiovascular risk reductionNikolaus Marx, Lars Rydén, Massimo Federici, et al.Cardiovascular Diabetology|October 13, 2020
Blood pressure and mortality in patients with type 2 diabetes and a recent coronary event in the ELIXA trialMagnus O Wijkman, Brian Claggett, Rafael Diaz, et al.Cancer Research|May 28, 2021
STK11/LKB1 Loss of Function Is Associated with Global DNA Hypomethylation and <i>S</i>-Adenosyl-Methionine Depletion in Human Lung AdenocarcinomaMichael J Koenig, Bernice A Agana, Jacob M Kaufman, et al.Genome Research|December 24, 2010
Prediction and characterization of noncoding RNAs in C. elegans by integrating conservation, secondary structure, and high-throughput sequencing and array dataZhi John Lu, Kevin Y Yip, Guilin Wang, et al.Circulation|December 29, 2006
Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes AssociationJohn B Buse, Henry N Ginsberg, George L Bakris, et al.The Biochemical Journal|March 6, 2015
Metformin and salicylate synergistically activate liver AMPK, inhibit lipogenesis and improve insulin sensitivityRebecca J Ford, Morgan D Fullerton, Stephen L Pinkosky, et al.Pageof 160